Found 19 matching trials
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma PHASE2 This is a single-arm, multicenter, exploratory clinical study evaluating th...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC PHASE3 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma PHASE2 Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Hep...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Neoadjuvant TACiE in Locally Advanced Gastric Cancer PHASE2 This is a prospective, single-center, single-arm, phase 2 trial to evaluate...
Show More Location
ZhongShan hospital FuDan university
Learn More & Join Trial
Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC PHASE2 This study aimed to evaluate the efficacy and the safety of the anti-progra...
Show More Location
the First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion PHASE4 Whether preoperative transarterial chemoembolization can prolong survival f...
Show More Location
SunYat-sen University cancer center
Learn More & Join Trial
Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma PHASE3 Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Hep...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC PHASE2 This is a prospective, single-center, phase II study,to evaluate the effica...
Show More Location
The Third Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
A Study on the Safety and Effectiveness of IBI318 Combined With Conventional TACE (cTACE) as a Perioperative Treatment for Potentially Resected Hepatocellular Carcinoma PHASE1 The purpose of this phase Ib study is to assess the safety, tolerability an...
Show More Location
The First Affiliated Hospital Zhejiang University
Learn More & Join Trial